On March 19, 2021 Ampio Pharmaceuticals (NYSE American: AMPE), a clinical stage biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, reported that it has been invited to present at the Benzinga Biotech Small Cap Conference being held virtually on March 24 & 25, 2021 (Press release, Ampio, MAR 19, 2021, View Source [SID1234576914]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details are as follows:

Corporate Overview
Title: Ampio – Business & Pipeline Update
Date: March 24, 2021
Time: 2:00-2:20pm EDT on Track 2
Registration Link: View Source